Beta-Defensins: Mediators of Gastrointestinal Inflammation

β-防御素：胃肠道炎症的介质

• 批准号: 7588315
• 负责人: STEVEN M COHN
• 金额: $ 18.94万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-06-05 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7588315
• 关键词: Acute; Affect; Age; Agonist; Animals; Anti-Inflammatory Agents; Anti-inflammatory; Antibodies; Antigen-Presenting Cells; Area; Attenuated; Automobile Driving; Backcrossings; Bacteria; Binding; Biological Assay; Bone Marrow; CCR6 gene; CD4 Positive T Lymphocytes; CD80 gene; Cell Line; Cell surface; Cells; Chronic; Coculture Techniques; Colitis; Crohn' s disease; Defensins; Dendritic Cells; Dendritic cell activation; Development; Disease; Disease susceptibility; Effector Cell; Epithelial Cells; Experimental Models; Gastrointestinal tract structure; Generations; Goals; IL2RA gene; Immune; Immune response; Immune system; Immunity; Immunomodulators; Inflammation; Inflammation Mediators; Inflammatory; Inflammatory Bowel Diseases; Inflammatory Response; Inflammatory disease of the intestine; Interleukin-1; Interleukin-10; Interleukin-12; Interleukin-17; Interleukin-4; Interleukin-6; Intestinal Diseases; Intestines; Invaded; Knowledge; Letters; Ligands; Link; MHC Class II Genes; Measures; Mediating; Mediator of activation protein; Modeling; Molecular Profiling; Mus; Nature; Pathogenesis; Pathway interactions; Patients; Pennsylvania; Peroxidases; Phenotype; Plants; Play; Production; Proteins; Regulation; Research; Role; Severities; Severity of illness; Signal Transduction; Signaling Molecule; Stomach; Surface; System; T-Cell Activation; T-Lymphocyte; TNF gene; TNFSF5 gene; Thymidine; Time; Tissues; Toll-like receptors; Ulcerative Colitis; United States; Universities; Virginia; Well in self; beta-Defensins; beta-defensin-2; cytokine; gastrointestinal; injury and repair; interleukin-23; killings; macrophage; mouse model; pathogen; public health relevance; receptor; response; toll-like receptor 4

DESCRIPTION (provided by applicant): The body's defense system can be divided into two components, the innate and adaptive immune systems. The innate immune system acts as the first line of defense against invading pathogens (e.g., bacteria) and is found in plants and all animals. The response is very rapid, but often is unable to clear the infecting pathogen by itself, and therefore, it signals the adaptive immune system to help. The adaptive immune system is very specific and specialized at eliminating foreign pathogens from the body, but its response is slower and requires time to develop. Eventually, the invading pathogen is removed by the inflammatory response generated by the immune system. However, a prolonged and overactive inflammatory response can have detrimental effects on the body, as is seen in inflammatory bowel disease (IBD). The innate immune system detects foreign pathogens, such as bacteria, by recognizing components of the pathogen via receptors, termed toll-like receptors (TLRs). TLRs are located on the surface of specialized cells (dendritic cells and macrophages) and binding of the pathogenic component (agonist) causes them to become activated and release messenger molecules (called cytokines) that further stimulate the innate and adaptive immune systems. Additional components of the innate immune system are the epithelial cells that line the stomach and intestines. In addition to forming a physical barrier to pathogen invasion, epithelial cells also secrete small proteins, termed beta (2)-defensins, which are capable of killing bacteria. Recently, 2-defensins have been shown to activate dendritic cells and macrophages by a TLR-dependent mechanism and may represent a link between the innate and adaptive immune system. The goal of project outlined in the following proposal is to determine if 2-defensins play a critical role in the inflammatory response seen during gastrointestinal (GI) inflammation. Thus the project deals with the immune aspects and mechanism (i.e., pathogenesis) involved in the generation of GI inflammation. Although a great deal of research has been conducted in these areas, what initiates and causes the inflammatory response to persist has not been fully clarified. Evidence obtained from IBD patients demonstrate that defensins are significantly increased during active disease. Similar findings have been seen in mouse models of GI inflammation. We will employ experimental models of GI inflammation to characterize and determine the role of 2-defensins in the inflammatory mechanism mediating IBD. More specifically, we will (1) examine their ability to activate dendritic cells and macrophages by a TLR4-mediated pathway and promote an ensuing pro- inflammatory T cell (adaptive immune) response and (2) determine if animals lacking a specific 2-defensin, Defb1, are more or less susceptible to gastrointestinal inflammation. By evaluating the function of 2-defensins to activate immune cells, we will be able to further define the potential mechanism involved in the generation/perpetuation of chronic GI inflammatory disorders. By increasing our understanding of these mechanisms, a greater potential exists to develop new therapies to treat these disorders. PUBLIC HEALTH RELEVANCE: Chronic inflammatory diseases of the gastrointestinal tract, such as Crohn's disease and ulcerative colitis affect greater than 1 million people in the United States alone. In recent years, it has become increasingly apparent that the innate immune system and its components play a critical role in chronic gastrointestinal (GI) inflammation; however, the exact nature of their involvement remains to be fully elucidated. The ultimate goal of the proposed project is to evaluate the role of beta-defensins (key components of the innate immune system) in the pathogenesis of chronic gastrointestinal inflammation. By increasing our understanding and knowledge of components involved in the pathogenic mechanism of GI Inflammation, a greater potential exists to develop new therapies and treat these disorders.

描述（由申请人提供）：人体的防御系统可以分为两个组成部分，先天性和适应性免疫系统。先天性免疫系统充当抵抗入侵病原体（例如，细菌），并发现在植物和所有动物。这种反应非常迅速，但通常无法自行清除感染的病原体，因此，它向适应性免疫系统发出信号以提供帮助。适应性免疫系统非常特异，专门用于消除体内的外来病原体，但其反应较慢，需要时间才能发展。最终，入侵的病原体被免疫系统产生的炎症反应清除。然而，长期和过度活跃的炎症反应可能对身体产生不利影响，正如炎症性肠道疾病（IBD）中所见。先天性免疫系统通过经由称为toll样受体（TLR）的受体识别病原体的组分来检测外来病原体，例如细菌。TLR位于特化细胞（树突状细胞和巨噬细胞）的表面上，并且致病组分（激动剂）的结合导致它们被激活并释放进一步刺激先天性和适应性免疫系统的信使分子（称为细胞因子）。先天免疫系统的其他组成部分是排列在胃和肠中的上皮细胞。除了对病原体入侵形成物理屏障外，上皮细胞还分泌称为β（2）-防御素的小蛋白质，其能够杀死细菌。最近，2-防御素已被证明通过TLR依赖性机制激活树突状细胞和巨噬细胞，并可能代表先天性和适应性免疫系统之间的联系。在下面的提案中概述的项目的目标是确定2-防御素是否在胃肠道（GI）炎症期间观察到的炎症反应中起关键作用。因此，该项目涉及免疫方面和机制（即，发病机制）参与GI炎症的产生。虽然在这些领域进行了大量的研究，但引发和导致炎症反应持续存在的原因尚未完全阐明。从IBD患者获得的证据表明，防御素在活动性疾病期间显著增加。在胃肠道炎症的小鼠模型中也观察到了类似的发现。我们将采用胃肠道炎症的实验模型来表征和确定2-防御素在介导IBD的炎症机制中的作用。更具体地说，我们将（1）检查它们通过TLR 4介导的途径激活树突状细胞和巨噬细胞并促进随后的促炎性T细胞（适应性免疫）应答的能力，以及（2）确定缺乏特异性2-防御素Defb 1的动物是否或多或少对胃肠道炎症敏感。通过评估2-防御素激活免疫细胞的功能，我们将能够进一步确定参与慢性GI炎症性疾病的产生/持续的潜在机制。通过增加我们对这些机制的理解，开发治疗这些疾病的新疗法的潜力更大。公共卫生相关性：胃肠道的慢性炎性疾病，如克罗恩病和溃疡性结肠炎，仅在美国就影响超过100万人。近年来，先天免疫系统及其组分在慢性胃肠道（GI）炎症中发挥着关键作用，这一点越来越明显;然而，其参与的确切性质仍有待充分阐明。拟议项目的最终目标是评估β-防御素（先天免疫系统的关键组成部分）在慢性胃肠道炎症发病机制中的作用。通过增加我们对GI炎症致病机制中所涉及的组分的理解和知识，开发新疗法和治疗这些疾病的潜力更大。